packageOlokizumab

olokizumab

Extends from Pharmacolibrary.Interfaces.PartialSubstance (Identity and physicochemical constants of one drug (Drugs.Substances)).

Information

Olokizumab is an investigational monoclonal antibody that blocks interleukin signalling and has been studied as an immunosuppressive treatment. It is not an approved medicine and remains in the investigational stage.

Summary written by glm-5.3-flash from Wikidata Q7088501 and the WHO ATC classification; not checked by a person.

name:olokizumab
ATC codes:L04AC23
DrugBank:DB13127
Wikidata:Q7088501

Parameters

TypeNameDefaultDescription
Stringname (from PartialSubstance)""INN / common name
String[:]atcCodes (from PartialSubstance)fill("", 0)all WHO ATC codes of the drug
StringdrugbankId (from PartialSubstance)""e.g. DB00758
StringpubchemCid (from PartialSubstance)""PubChem compound id
StringchebiId (from PartialSubstance)""ChEBI id (number)
StringwikidataId (from PartialSubstance)""e.g. Q410238
Stringformula (from PartialSubstance)""molecular formula
Modelica.Units.SI.MolarMassM (from PartialSubstance)0molar mass; 0 = unknown
ReallogP (from PartialSubstance)Modelica.Constants.infoctanol-water partition coefficient (log10); inf = unknown